State infectious disease director Kris Ehresmann said Thursday that Minnesota will not be affected by the loss of 15 million doses of the Johnson & Johnson vaccine that were discarded due to quality issues.
Minnesota tops 2,000 daily cases for first time in months
→
Ehresmann said Johnson & Johnson is awaiting approval from the Food and Drug Administration for a large-scale manufacturing facility that will allow them to dramatically increase supply, but the number of allocated J&J doses will remain “erratic until they reach their stride.”
Walz to expand vaccine eligibility to Minnesotans over 16
→
